Example of how the EC does not see PIPas patients or as victims but as a lucrative & growing market of CONSUMERS!

The European Commission is moving medical devices including breast implants from HEALTH to INDUSTRY!!! This is an example of how the EC does not see us as patients or as victims but as a lucrative & growing market of CONSUMERS!

Joint press release] Is President-elect Juncker erecting a smoke screen around patient safety?
 28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament.
 " I was always clear that medical devices, just like medicines, are first and foremost about health, and should not be treated as ordinary products. The ambiguity of Mr Juncker’s statement, and his subsequent silence on the issue, is of real concern," said Glenis Willmott MEP UK rapporteur on the Clinical Trials Regulation and Medical Devices Regulation." 
 As the Poly Implant Prostheses (PIP) scandal over faulty breast implants demonstrated (3), it is crucial to ensure that patients are supplied with high quality and safe medical devices and health technologies. By placing these under the responsibility of Internal Market and Industry, Mr Juncker risks compromising patient safety for industrial interests.Read more



Open letter to President-elect Jean-Claude Juncker] Are we to understand that the portfolios for medical devices and health technologies will not remain with the Health Commissioner?

Dear President-elect Jean-Claude Juncker,
While welcoming your decision on medicines and pharmaceutical products, your statement to the European Parliament (3) was nonetheless vague and lacked clarity, which is of concern to us and leaves us with the following question .. Are we to understand that the portfolios for medical devices and health technologies will not remain with the Health Commissioner?
" As explained in our previous letter, it is of equal importance that these portfolios also remain the sole responsibility of the Health Commissioner. As the PIP scandal over faulty breast implants and other controversies about defective medical devices have demonstrated, it is crucial to ensure that patients are supplied with high quality and safe medical devices and health technologies; the primary function of which is to provide people with a better quality of life "
Read more 


" patient safety must never be undermined by industry interests" #PIP #HIP #MESH 
" it is crucial to ensure that patients are supplied with high quality & safe medical devices & health technologies " 
"  100,000 EU women, including mothers & women recovering from cancer are victims of #PIP global health fraud."
" 21 organisations in Europe are fighting to stop this move by the European Commission. "